Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARMUSTINE Cause Therapy partial responder? 59 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Therapy partial responder have been filed in association with CARMUSTINE (carmustine). This represents 1.8% of all adverse event reports for CARMUSTINE.

59
Reports of Therapy partial responder with CARMUSTINE
1.8%
of all CARMUSTINE reports
10
Deaths
12
Hospitalizations

How Dangerous Is Therapy partial responder From CARMUSTINE?

Of the 59 reports, 10 (16.9%) resulted in death, 12 (20.3%) required hospitalization, and 11 (18.6%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 59 reports have been filed with the FAERS database.

What Other Side Effects Does CARMUSTINE Cause?

Off label use (454) Febrile neutropenia (297) Myelodysplastic syndrome (295) Disease progression (241) Acute myeloid leukaemia (180) Thrombocytopenia (174) Pyrexia (152) Drug ineffective (149) Mucosal inflammation (148) Second primary malignancy (141)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which CARMUSTINE Alternatives Have Lower Therapy partial responder Risk?

CARMUSTINE vs CARTEOLOL CARMUSTINE vs CARVEDILOL CARMUSTINE vs CASIMERSEN CARMUSTINE vs CASIRIVIMAB CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB

Related Pages

CARMUSTINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder CARMUSTINE Demographics